Skip to main content

Rabbit Monoclonal CXCL5 antibody. Suitable for IP, WB and reacts with Human, Recombinant fragment - Human samples. Cited in 7 publications.

Be the first to review this product! Submit a review

Images

Immunoprecipitation - Anti-CXCL5 + CXCL6 antibody [EP13083] (AB198505), expandable thumbnail
  • Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (AB198505), expandable thumbnail
  • Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (AB198505), expandable thumbnail

Publications

Key facts

Isotype
IgG
Host species
Rabbit
Storage buffer

pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA

Form
Liquid
Clonality
Monoclonal

Immunogen

  • The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
IPWBIHC-P
Human
Tested
Tested
Not recommended
Recombinant fragment - Human
Not recommended
Tested
Not recommended

Tested
Tested

Species
Human
Dilution info
1/30
Notes

Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Not recommended
Not recommended

Species
Recombinant fragment - Human
Dilution info
-
Notes

-

Tested
Tested

Species
Human
Dilution info
1/10000
Notes

-

Species
Recombinant fragment - Human
Dilution info
1/10000
Notes

-

Not recommended
Not recommended

Species
Human
Dilution info
-
Notes

Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Species
Recombinant fragment - Human
Dilution info
-
Notes

-

Associated Products

Select an associated product type

2 products for Alternative Product

Target data

Function

Involved in neutrophil activation. In vitro, ENA-78(8-78) and ENA-78(9-78) show a threefold higher chemotactic activity for neutrophil granulocytes.

Additional Targets

CXCL6

Alternative names

Recommended products

Rabbit Monoclonal CXCL5 antibody. Suitable for IP, WB and reacts with Human, Recombinant fragment - Human samples. Cited in 7 publications.

Key facts

Isotype
IgG
Form
Liquid
Clonality
Monoclonal
Immunogen
  • The exact immunogen used to generate this antibody is proprietary information.
Clone number
EP13083
Purification technique
Affinity purification Protein A
Concentration
Loading...

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Notes

The production method for this product has been changed from hybridoma to recombinant on 15th April 2024.

Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

C-X-C motif chemokine ligands 5 and 6 (CXCL5 and CXCL6) also known as ENA-78 and GCP-2 respectively are small proteins with a molecular mass of approximately 12 kDa. These chemokines belong to the CXC chemokine family and play key roles as signaling proteins. CXCL5 and CXCL6 are mainly expressed in neutrophils epithelial cells and to some extent in macrophages. When they bind to their receptor CXCR2 they induce chemotaxis guiding immune cells toward sites of inflammation or injury.

Biological function summary

They coordinate immune response by mediating neutrophil recruitment to inflammatory sites. CXCL5 and CXCL6 often work as a team binding CXCR2 and aiding in protective tissue responses. Their roles extend further as they partake in triggering angiogenesis the formation of new blood vessels under physiological or pathological conditions such as wound healing or cancer. These activities imply their involvement in complex cellular networks and interactions.

Pathways

The involvement of CXCL5 and CXCL6 arises prominently in the NF-kB pathway and the MAPK signaling pathway. These pathways integral to immune and inflammatory responses reflect the chemokines' interaction with proteins like IL-8 and TNF-alpha emphasizing their importance in host defense mechanisms and inflammatory signaling cascades. Their ability to engage with these pathways demonstrates an essential role in modulating the intensity and duration of inflammatory responses.

Associated diseases and disorders

CXCL5 and CXCL6 relate to conditions such as cancer and rheumatoid arthritis. In cancer these chemokines can enhance tumor progression by increasing angiogenesis and attracting cells that promote tumor growth. Similarly in rheumatoid arthritis their overexpression correlates with joint inflammation and tissue damage. Proteins like VEGF-A connected to these chemokines further underline their association with pathological angiogenesis and inflammatory process regulation in disease states.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

3 product images

  • Immunoprecipitation - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505), expandable thumbnail

    Immunoprecipitation - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505)

    CXCL5 + CXCL6 was immunoprecipitated from 0.35 mg of A549 (Human lung carcinoma cell line) whole cell extract with ab198505 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab198505 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366), was used as secondary antibody at 1/5000 dilution.


    Lane 1: A549 (Human lung carcinoma epithelial cell), whole cell lysate, 10µg

    Lane 2: A549 whole cell lysate with the ab198505 at 1/30 dilution

    Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab198505 in A549 whole cell lysate

    All lanes: Immunoprecipitation - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505) at 1/1000 dilution

    All lanes: A549 (Human lung carcinoma epithelial cell), whole cell lysate

    Secondary

    All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/5000 dilution

    Predicted band size: 12 kDa

    Exposure time: 93s

  • Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505), expandable thumbnail

    Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505)

    The expression of CXCL5 and CXCL6 is induced by TNF-a and PMA. (PMID 9057843; PMID: 23922745).

    Anti-GAPDH antibody [EPR16891] - Loading Control ab181602 was used a GAPDH loading control.

    All lanes: Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505) at 1/10000 dilution

    Lane 1: HEK-293T cells transfected with an empty expression vector containing His tag, hole cell lysate with 5% NFDM/TBST

    Lane 2: HEK-293T cells transfected with a human CXCL5 expression vector containing His tag, then treated with 600 ng/ml BFA for 3h, whole cell lysate with 5% NFDM/TBST

    Lane 3: HEK-293T cells transfected with a human CXCL6 expression vector containing His tag, then treated with 600 ng/ml BFA for 3h, whole cell lysate with 5% NFDM/TBST

    Secondary

    All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution

    Predicted band size: 12 kDa

    Exposure time: 10s

  • Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505), expandable thumbnail

    Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505)

    The expression of CXCL5 and CXCL6 is induced by TNF-a and PMA. (PMID 9057843; PMID: 23922745).

    Anti-GAPDH antibody [EPR16891] - Loading Control ab181602 was used a GAPDH loading control.

    All lanes: Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505) at 1/10000 dilution

    Lane 1: A549 (Human lung carcinoma epithelial cell) starved overnight, whole cell lysate at 15 µg with 5% NFDM/TBST

    Lane 2: A549 (Human lung carcinoma epithelial cell) starved overnight, then treated with 10ng/ml TNF-a, 10nM TPA and 0.1% BSA for 24 hours, whole cell lysate at 15 µg with 5% NFDM/TBST

    Secondary

    All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution

    Predicted band size: 12 kDa

    Exposure time: 10s

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com